271 related articles for article (PubMed ID: 31585768)
1. Current understanding of fibrosis in genetic cardiomyopathies.
Eijgenraam TR; Silljé HHW; de Boer RA
Trends Cardiovasc Med; 2020 Aug; 30(6):353-361. PubMed ID: 31585768
[TBL] [Abstract][Full Text] [Related]
2. A primer on current progress in cardiac fibrosis.
Al Hattab D; Czubryt MP
Can J Physiol Pharmacol; 2017 Oct; 95(10):1091-1099. PubMed ID: 28273426
[TBL] [Abstract][Full Text] [Related]
3. Serum versus Imaging Biomarkers in Friedreich Ataxia to Indicate Left Ventricular Remodeling and Outcomes.
Mehta N; Chacko P; Jin J; Tran T; Prior TW; He X; Agarwal G; Raman SV
Tex Heart Inst J; 2016 Aug; 43(4):305-10. PubMed ID: 27547137
[TBL] [Abstract][Full Text] [Related]
4. Employing Extracellular Volume Cardiovascular Magnetic Resonance Measures of Myocardial Fibrosis to Foster Novel Therapeutics.
Schelbert EB; Sabbah HN; Butler J; Gheorghiade M
Circ Cardiovasc Imaging; 2017 Jun; 10(6):. PubMed ID: 28512159
[TBL] [Abstract][Full Text] [Related]
5. The role of mutations in the SCN5A gene in cardiomyopathies.
Zaklyazminskaya E; Dzemeshkevich S
Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1799-805. PubMed ID: 26916278
[TBL] [Abstract][Full Text] [Related]
6. Distinct fibrosis pattern in desmosomal and phospholamban mutation carriers in hereditary cardiomyopathies.
Sepehrkhouy S; Gho JMIH; van Es R; Harakalova M; de Jonge N; Dooijes D; van der Smagt JJ; Buijsrogge MP; Hauer RNW; Goldschmeding R; de Weger RA; Asselbergs FW; Vink A
Heart Rhythm; 2017 Jul; 14(7):1024-1032. PubMed ID: 28365402
[TBL] [Abstract][Full Text] [Related]
7. Progressive cardiac dysfunction and fibrosis in the cardiomyopathic hamster and effects of growth hormone and angiotensin-converting enzyme inhibition.
Ryoke T; Gu Y; Mao L; Hongo M; Clark RG; Peterson KL; Ross J
Circulation; 1999 Oct; 100(16):1734-43. PubMed ID: 10525494
[TBL] [Abstract][Full Text] [Related]
8. Patterns of myocardial fibrosis in idiopathic cardiomyopathies and chronic Chagasic cardiopathy.
Rossi MA
Can J Cardiol; 1991 Sep; 7(7):287-94. PubMed ID: 1933634
[TBL] [Abstract][Full Text] [Related]
9. Epigenetics in Reactive and Reparative Cardiac Fibrogenesis: The Promise of Epigenetic Therapy.
Ghosh AK; Rai R; Flevaris P; Vaughan DE
J Cell Physiol; 2017 Aug; 232(8):1941-1956. PubMed ID: 27883184
[TBL] [Abstract][Full Text] [Related]
10. Classification, Epidemiology, and Global Burden of Cardiomyopathies.
McKenna WJ; Maron BJ; Thiene G
Circ Res; 2017 Sep; 121(7):722-730. PubMed ID: 28912179
[TBL] [Abstract][Full Text] [Related]
11. Primary Myocardial Fibrosis as an Alternative Phenotype Pathway of Inherited Cardiac Structural Disorders.
Junttila MJ; Holmström L; Pylkäs K; Mantere T; Kaikkonen K; Porvari K; Kortelainen ML; Pakanen L; Kerkelä R; Myerburg RJ; Huikuri HV
Circulation; 2018 Jun; 137(25):2716-2726. PubMed ID: 29915098
[TBL] [Abstract][Full Text] [Related]
12. Embryonic stem cell therapy of heart failure in genetic cardiomyopathy.
Yamada S; Nelson TJ; Crespo-Diaz RJ; Perez-Terzic C; Liu XK; Miki T; Seino S; Behfar A; Terzic A
Stem Cells; 2008 Oct; 26(10):2644-53. PubMed ID: 18669912
[TBL] [Abstract][Full Text] [Related]
13. Cardiomyopathy: a necessary revision of the WHO classification.
Boffa GM; Thiene G; Nava A; Dalla Volta S
Int J Cardiol; 1991 Jan; 30(1):1-7. PubMed ID: 1991658
[TBL] [Abstract][Full Text] [Related]
14. Correlation between right ventricular T
Jellis CL; Yingchoncharoen T; Gai N; Kusunose K; Popović ZB; Flamm S; Kwon D
Int J Cardiovasc Imaging; 2018 Jan; 34(1):55-65. PubMed ID: 28357724
[TBL] [Abstract][Full Text] [Related]
15. Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis.
Yu L; Ruifrok WP; Meissner M; Bos EM; van Goor H; Sanjabi B; van der Harst P; Pitt B; Goldstein IJ; Koerts JA; van Veldhuisen DJ; Bank RA; van Gilst WH; Silljé HH; de Boer RA
Circ Heart Fail; 2013 Jan; 6(1):107-17. PubMed ID: 23230309
[TBL] [Abstract][Full Text] [Related]
16. Potential reduction of interstitial myocardial fibrosis with renal denervation.
Doltra A; Messroghli D; Stawowy P; Hassel JH; Gebker R; Leppänen O; Gräfe M; Schneeweis C; Schnackenburg B; Fleck E; Kelle S
J Am Heart Assoc; 2014 Dec; 3(6):e001353. PubMed ID: 25516438
[TBL] [Abstract][Full Text] [Related]
17. Magnetic Resonance Characterization of Cardiac Adaptation and Myocardial Fibrosis in Pulmonary Hypertension Secondary to Systemic-To-Pulmonary Shunt.
Pereda D; García-Lunar I; Sierra F; Sánchez-Quintana D; Santiago E; Ballesteros C; Encalada JF; Sánchez-González J; Fuster V; Ibáñez B; García-Álvarez A
Circ Cardiovasc Imaging; 2016 Sep; 9(9):. PubMed ID: 27601365
[TBL] [Abstract][Full Text] [Related]
18. Functional brown adipose tissue limits cardiomyocyte injury and adverse remodeling in catecholamine-induced cardiomyopathy.
Thoonen R; Ernande L; Cheng J; Nagasaka Y; Yao V; Miranda-Bezerra A; Chen C; Chao W; Panagia M; Sosnovik DE; Puppala D; Armoundas AA; Hindle A; Bloch KD; Buys ES; Scherrer-Crosbie M
J Mol Cell Cardiol; 2015 Jul; 84():202-11. PubMed ID: 25968336
[TBL] [Abstract][Full Text] [Related]
19. Cardiomyopathies and myocardial disorders in Africa: present status and the way forward.
Falase AO; Ogah OS
Cardiovasc J Afr; 2012 Nov; 23(10):552-62. PubMed ID: 23192260
[TBL] [Abstract][Full Text] [Related]
20. Inherited cardiomyopathies mimicking arrhythmogenic right ventricular cardiomyopathy.
Roberts JD; Veinot JP; Rutberg J; Gollob MH
Cardiovasc Pathol; 2010; 19(5):316-20. PubMed ID: 19632136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
